Cart
sales@molnova.com
GW842166X
CAS No. 666260-75-9
GW842166X( GW-842166X; 842166X; 842166 )
Catalog No. M18967 CAS No. 666260-75-9
GW842166X is a potent and highly selective agonist of cannabinoid receptor CB2 receptor with EC50 of 63 nM, shows no significant activity at CB1 receptor. Phase 2.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500mg | Get Quote | In Stock |
|
| 250mg | Get Quote | In Stock |
|
| 25mg | 234 | In Stock |
|
| 10mg | 126 | In Stock |
|
| 5mg | 72 | In Stock |
|
Biological Information
-
Product NameGW842166X
-
NoteResearch use only, not for human use.
-
Brief DescriptionGW842166X is a potent and highly selective agonist of cannabinoid receptor CB2 receptor with EC50 of 63 nM, shows no significant activity at CB1 receptor. Phase 2.
-
DescriptionGW 842166X is a cannabinoid receptor 2 (CB2) agonist potentially for the treatment of inflammatory pain.
-
SynonymsGW-842166X; 842166X; 842166
-
PathwayCell Cycle/DNA Damage
-
TargetTopoisomerase
-
RecptorCB2
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number666260-75-9
-
Formula Weight449.25
-
Molecular FormulaC18H17Cl2F3N4O2
-
Purity98%
-
SolubilityDMSO : ≥ 83.3 mg/mL; 185.42 mM
-
SMILESFC(F)(F)C1=NC(NC2=CC=C(Cl)C=C2Cl)=NC=C1C(=O)NCC1CCOCC1
-
Chemical Name2-((2,4-dichlorophenyl)amino)-N-((tetrahydro-2H-pyran-4-yl)methyl)-4-(trifluoromethyl)pyrimidine-5-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Giblin GM, et al. J Med Chem, 2007, 50(11), 2597-2600.
molnova catalog
related products
-
Lomefloxacin hydroch...
Lomefloxacin hydrochloride (Maxaquin) is a hydrochloride salt of lomefloxacin and is a fluoroquinolone antibiotic.
-
Irinotecan
Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.
-
SN-38
LE-SN38 is NeoPharm’s NeoLipid liposomal formulation of SN-38, the active metabolite of irinotecan (Camptosar), a chemotherapeutic pro-drug approved for the treatment of advanced colorectal Y.
